- Home
- CLPS vs BNR Comparison
CLPS vs BNR Comparison
Compare CLPS & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- BNR
- Stock Information
- Founded
- CLPS 2005
- BNR 2014
- Country
- CLPS Hong Kong
- BNR China
- Employees
- CLPS N/A
- BNR N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- BNR Medical Specialities
- Sector
- CLPS Technology
- BNR Health Care
- Exchange
- CLPS Nasdaq
- BNR Nasdaq
- Market Cap
- CLPS 26.3M
- BNR 29.1M
- IPO Year
- CLPS 2018
- BNR 2020
- Fundamental
- Price
- CLPS $1.00
- BNR $3.66
- Analyst Decision
- CLPS
- BNR
- Analyst Count
- CLPS 0
- BNR 0
- Target Price
- CLPS N/A
- BNR N/A
- AVG Volume (30 Days)
- CLPS 11.6K
- BNR 38.6K
- Earning Date
- CLPS 03-05-2025
- BNR 06-06-2025
- Dividend Yield
- CLPS 13.13%
- BNR N/A
- EPS Growth
- CLPS N/A
- BNR N/A
- EPS
- CLPS N/A
- BNR N/A
- Revenue
- CLPS $153,816,045.00
- BNR $72,112,038.00
- Revenue This Year
- CLPS N/A
- BNR $136.32
- Revenue Next Year
- CLPS N/A
- BNR N/A
- P/E Ratio
- CLPS N/A
- BNR N/A
- Revenue Growth
- CLPS 5.81
- BNR 0.53
- 52 Week Low
- CLPS $0.68
- BNR $2.18
- 52 Week High
- CLPS $1.70
- BNR $7.90
- Technical
- Relative Strength Index (RSI)
- CLPS 53.85
- BNR 58.05
- Support Level
- CLPS $0.90
- BNR $3.38
- Resistance Level
- CLPS $1.08
- BNR $4.19
- Average True Range (ATR)
- CLPS 0.06
- BNR 0.41
- MACD
- CLPS 0.01
- BNR 0.07
- Stochastic Oscillator
- CLPS 55.56
- BNR 61.87
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.